Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience
The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less wi...
Ausführliche Beschreibung
Autor*in: |
Mooradian, Meghan J. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2019 |
---|
Umfang: |
6 |
---|
Übergeordnetes Werk: |
Enthalten in: Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values - Hedayati, Sara ELSEVIER, 2016transfer abstract, Philadelphia, Pa |
---|---|
Übergeordnetes Werk: |
volume:48 ; year:2019 ; number:6 ; pages:1127-1132 ; extent:6 |
Links: |
---|
DOI / URN: |
10.1016/j.semarthrit.2018.10.012 |
---|
Katalog-ID: |
ELV046881441 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV046881441 | ||
003 | DE-627 | ||
005 | 20230624130024.0 | ||
007 | cr uuu---uuuuu | ||
008 | 191021s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.semarthrit.2018.10.012 |2 doi | |
028 | 5 | 2 | |a GBV00000000000720.pica |
035 | |a (DE-627)ELV046881441 | ||
035 | |a (ELSEVIER)S0049-0172(18)30442-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 540 |q VZ |
082 | 0 | 4 | |a 570 |q VZ |
082 | 0 | 4 | |a 570 |a 610 |q VZ |
084 | |a 58.30 |2 bkl | ||
084 | |a 50.22 |2 bkl | ||
084 | |a 44.09 |2 bkl | ||
100 | 1 | |a Mooradian, Meghan J. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience |
264 | 1 | |c 2019 | |
300 | |a 6 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. | ||
700 | 1 | |a Nasrallah, Mazen |4 oth | |
700 | 1 | |a Gainor, Justin F. |4 oth | |
700 | 1 | |a Reynolds, Kerry L. |4 oth | |
700 | 1 | |a Cohen, Justine V. |4 oth | |
700 | 1 | |a Lawrence, Donald P. |4 oth | |
700 | 1 | |a Miloslavsky, Eli M. |4 oth | |
700 | 1 | |a Kohler, Minna J. |4 oth | |
700 | 1 | |a Sullivan, Ryan J. |4 oth | |
700 | 1 | |a Schoenfeld, Sara R. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Saunders |a Hedayati, Sara ELSEVIER |t Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |d 2016transfer abstract |g Philadelphia, Pa |w (DE-627)ELV013670425 |
773 | 1 | 8 | |g volume:48 |g year:2019 |g number:6 |g pages:1127-1132 |g extent:6 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.semarthrit.2018.10.012 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_181 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
936 | b | k | |a 58.30 |j Biotechnologie |q VZ |
936 | b | k | |a 50.22 |j Sensorik |q VZ |
936 | b | k | |a 44.09 |j Medizintechnik |q VZ |
951 | |a AR | ||
952 | |d 48 |j 2019 |e 6 |h 1127-1132 |g 6 |
author_variant |
m j m mj mjm |
---|---|
matchkey_str |
mooradianmeghanjnasrallahmazengainorjust:2019----:uclseearemtcopiainoimncekonihbtrhr |
hierarchy_sort_str |
2019 |
bklnumber |
58.30 50.22 44.09 |
publishDate |
2019 |
allfields |
10.1016/j.semarthrit.2018.10.012 doi GBV00000000000720.pica (DE-627)ELV046881441 (ELSEVIER)S0049-0172(18)30442-6 DE-627 ger DE-627 rakwb eng 540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl Mooradian, Meghan J. verfasserin aut Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. Nasrallah, Mazen oth Gainor, Justin F. oth Reynolds, Kerry L. oth Cohen, Justine V. oth Lawrence, Donald P. oth Miloslavsky, Eli M. oth Kohler, Minna J. oth Sullivan, Ryan J. oth Schoenfeld, Sara R. oth Enthalten in Saunders Hedayati, Sara ELSEVIER Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values 2016transfer abstract Philadelphia, Pa (DE-627)ELV013670425 volume:48 year:2019 number:6 pages:1127-1132 extent:6 https://doi.org/10.1016/j.semarthrit.2018.10.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 58.30 Biotechnologie VZ 50.22 Sensorik VZ 44.09 Medizintechnik VZ AR 48 2019 6 1127-1132 6 |
spelling |
10.1016/j.semarthrit.2018.10.012 doi GBV00000000000720.pica (DE-627)ELV046881441 (ELSEVIER)S0049-0172(18)30442-6 DE-627 ger DE-627 rakwb eng 540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl Mooradian, Meghan J. verfasserin aut Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. Nasrallah, Mazen oth Gainor, Justin F. oth Reynolds, Kerry L. oth Cohen, Justine V. oth Lawrence, Donald P. oth Miloslavsky, Eli M. oth Kohler, Minna J. oth Sullivan, Ryan J. oth Schoenfeld, Sara R. oth Enthalten in Saunders Hedayati, Sara ELSEVIER Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values 2016transfer abstract Philadelphia, Pa (DE-627)ELV013670425 volume:48 year:2019 number:6 pages:1127-1132 extent:6 https://doi.org/10.1016/j.semarthrit.2018.10.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 58.30 Biotechnologie VZ 50.22 Sensorik VZ 44.09 Medizintechnik VZ AR 48 2019 6 1127-1132 6 |
allfields_unstemmed |
10.1016/j.semarthrit.2018.10.012 doi GBV00000000000720.pica (DE-627)ELV046881441 (ELSEVIER)S0049-0172(18)30442-6 DE-627 ger DE-627 rakwb eng 540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl Mooradian, Meghan J. verfasserin aut Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. Nasrallah, Mazen oth Gainor, Justin F. oth Reynolds, Kerry L. oth Cohen, Justine V. oth Lawrence, Donald P. oth Miloslavsky, Eli M. oth Kohler, Minna J. oth Sullivan, Ryan J. oth Schoenfeld, Sara R. oth Enthalten in Saunders Hedayati, Sara ELSEVIER Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values 2016transfer abstract Philadelphia, Pa (DE-627)ELV013670425 volume:48 year:2019 number:6 pages:1127-1132 extent:6 https://doi.org/10.1016/j.semarthrit.2018.10.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 58.30 Biotechnologie VZ 50.22 Sensorik VZ 44.09 Medizintechnik VZ AR 48 2019 6 1127-1132 6 |
allfieldsGer |
10.1016/j.semarthrit.2018.10.012 doi GBV00000000000720.pica (DE-627)ELV046881441 (ELSEVIER)S0049-0172(18)30442-6 DE-627 ger DE-627 rakwb eng 540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl Mooradian, Meghan J. verfasserin aut Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. Nasrallah, Mazen oth Gainor, Justin F. oth Reynolds, Kerry L. oth Cohen, Justine V. oth Lawrence, Donald P. oth Miloslavsky, Eli M. oth Kohler, Minna J. oth Sullivan, Ryan J. oth Schoenfeld, Sara R. oth Enthalten in Saunders Hedayati, Sara ELSEVIER Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values 2016transfer abstract Philadelphia, Pa (DE-627)ELV013670425 volume:48 year:2019 number:6 pages:1127-1132 extent:6 https://doi.org/10.1016/j.semarthrit.2018.10.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 58.30 Biotechnologie VZ 50.22 Sensorik VZ 44.09 Medizintechnik VZ AR 48 2019 6 1127-1132 6 |
allfieldsSound |
10.1016/j.semarthrit.2018.10.012 doi GBV00000000000720.pica (DE-627)ELV046881441 (ELSEVIER)S0049-0172(18)30442-6 DE-627 ger DE-627 rakwb eng 540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl Mooradian, Meghan J. verfasserin aut Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. Nasrallah, Mazen oth Gainor, Justin F. oth Reynolds, Kerry L. oth Cohen, Justine V. oth Lawrence, Donald P. oth Miloslavsky, Eli M. oth Kohler, Minna J. oth Sullivan, Ryan J. oth Schoenfeld, Sara R. oth Enthalten in Saunders Hedayati, Sara ELSEVIER Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values 2016transfer abstract Philadelphia, Pa (DE-627)ELV013670425 volume:48 year:2019 number:6 pages:1127-1132 extent:6 https://doi.org/10.1016/j.semarthrit.2018.10.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 58.30 Biotechnologie VZ 50.22 Sensorik VZ 44.09 Medizintechnik VZ AR 48 2019 6 1127-1132 6 |
language |
English |
source |
Enthalten in Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values Philadelphia, Pa volume:48 year:2019 number:6 pages:1127-1132 extent:6 |
sourceStr |
Enthalten in Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values Philadelphia, Pa volume:48 year:2019 number:6 pages:1127-1132 extent:6 |
format_phy_str_mv |
Article |
bklname |
Biotechnologie Sensorik Medizintechnik |
institution |
findex.gbv.de |
dewey-raw |
540 |
isfreeaccess_bool |
false |
container_title |
Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |
authorswithroles_txt_mv |
Mooradian, Meghan J. @@aut@@ Nasrallah, Mazen @@oth@@ Gainor, Justin F. @@oth@@ Reynolds, Kerry L. @@oth@@ Cohen, Justine V. @@oth@@ Lawrence, Donald P. @@oth@@ Miloslavsky, Eli M. @@oth@@ Kohler, Minna J. @@oth@@ Sullivan, Ryan J. @@oth@@ Schoenfeld, Sara R. @@oth@@ |
publishDateDaySort_date |
2019-01-01T00:00:00Z |
hierarchy_top_id |
ELV013670425 |
dewey-sort |
3540 |
id |
ELV046881441 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV046881441</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624130024.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.semarthrit.2018.10.012</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000720.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV046881441</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-0172(18)30442-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.30</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.22</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.09</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mooradian, Meghan J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less widely recognized and characterized.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nasrallah, Mazen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gainor, Justin F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reynolds, Kerry L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohen, Justine V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lawrence, Donald P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miloslavsky, Eli M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kohler, Minna J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sullivan, Ryan J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schoenfeld, Sara R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Saunders</subfield><subfield code="a">Hedayati, Sara ELSEVIER</subfield><subfield code="t">Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values</subfield><subfield code="d">2016transfer abstract</subfield><subfield code="g">Philadelphia, Pa</subfield><subfield code="w">(DE-627)ELV013670425</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:48</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:1127-1132</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.semarthrit.2018.10.012</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_181</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.30</subfield><subfield code="j">Biotechnologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.22</subfield><subfield code="j">Sensorik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.09</subfield><subfield code="j">Medizintechnik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">48</subfield><subfield code="j">2019</subfield><subfield code="e">6</subfield><subfield code="h">1127-1132</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
author |
Mooradian, Meghan J. |
spellingShingle |
Mooradian, Meghan J. ddc 540 ddc 570 bkl 58.30 bkl 50.22 bkl 44.09 Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience |
authorStr |
Mooradian, Meghan J. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV013670425 |
format |
electronic Article |
dewey-ones |
540 - Chemistry & allied sciences 570 - Life sciences; biology 610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience |
topic |
ddc 540 ddc 570 bkl 58.30 bkl 50.22 bkl 44.09 |
topic_unstemmed |
ddc 540 ddc 570 bkl 58.30 bkl 50.22 bkl 44.09 |
topic_browse |
ddc 540 ddc 570 bkl 58.30 bkl 50.22 bkl 44.09 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
m n mn j f g jf jfg k l r kl klr j v c jv jvc d p l dp dpl e m m em emm m j k mj mjk r j s rj rjs s r s sr srs |
hierarchy_parent_title |
Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |
hierarchy_parent_id |
ELV013670425 |
dewey-tens |
540 - Chemistry 570 - Life sciences; biology 610 - Medicine & health |
hierarchy_top_title |
Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV013670425 |
title |
Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience |
ctrlnum |
(DE-627)ELV046881441 (ELSEVIER)S0049-0172(18)30442-6 |
title_full |
Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience |
author_sort |
Mooradian, Meghan J. |
journal |
Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |
journalStr |
Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science 600 - Technology |
recordtype |
marc |
publishDateSort |
2019 |
contenttype_str_mv |
zzz |
container_start_page |
1127 |
author_browse |
Mooradian, Meghan J. |
container_volume |
48 |
physical |
6 |
class |
540 VZ 570 VZ 570 610 VZ 58.30 bkl 50.22 bkl 44.09 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Mooradian, Meghan J. |
doi_str_mv |
10.1016/j.semarthrit.2018.10.012 |
dewey-full |
540 570 610 |
title_sort |
musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: a single center experience |
title_auth |
Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience |
abstract |
The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. |
abstractGer |
The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. |
abstract_unstemmed |
The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_40 GBV_ILN_65 GBV_ILN_181 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2008 GBV_ILN_2010 GBV_ILN_2011 |
container_issue |
6 |
title_short |
Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience |
url |
https://doi.org/10.1016/j.semarthrit.2018.10.012 |
remote_bool |
true |
author2 |
Nasrallah, Mazen Gainor, Justin F. Reynolds, Kerry L. Cohen, Justine V. Lawrence, Donald P. Miloslavsky, Eli M. Kohler, Minna J. Sullivan, Ryan J. Schoenfeld, Sara R. |
author2Str |
Nasrallah, Mazen Gainor, Justin F. Reynolds, Kerry L. Cohen, Justine V. Lawrence, Donald P. Miloslavsky, Eli M. Kohler, Minna J. Sullivan, Ryan J. Schoenfeld, Sara R. |
ppnlink |
ELV013670425 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.semarthrit.2018.10.012 |
up_date |
2024-07-06T21:23:04.444Z |
_version_ |
1803866325065400320 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV046881441</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624130024.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.semarthrit.2018.10.012</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000720.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV046881441</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-0172(18)30442-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.30</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.22</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.09</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mooradian, Meghan J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events (irAEs). While certain toxicities have been well studied, rheumatic complications have been less widely recognized and characterized.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nasrallah, Mazen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gainor, Justin F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reynolds, Kerry L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohen, Justine V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lawrence, Donald P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miloslavsky, Eli M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kohler, Minna J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sullivan, Ryan J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schoenfeld, Sara R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Saunders</subfield><subfield code="a">Hedayati, Sara ELSEVIER</subfield><subfield code="t">Physical properties of pregelatinized and granular cold water swelling maize starches at different pH values</subfield><subfield code="d">2016transfer abstract</subfield><subfield code="g">Philadelphia, Pa</subfield><subfield code="w">(DE-627)ELV013670425</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:48</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:1127-1132</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.semarthrit.2018.10.012</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_181</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.30</subfield><subfield code="j">Biotechnologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.22</subfield><subfield code="j">Sensorik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.09</subfield><subfield code="j">Medizintechnik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">48</subfield><subfield code="j">2019</subfield><subfield code="e">6</subfield><subfield code="h">1127-1132</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
score |
7.398967 |